Effect of Siddharthakadi Basti in Retained products of conceptio
Phase 2
- Conditions
- Health Condition 1: O73- Retained placenta and membranes, without hemorrhage
- Registration Number
- CTRI/2024/03/064729
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Married Female Patient of age 18-45 years old.
2. Thick irregular endometrium on trans-vaginal sonography suggesting RPOC.
(ICD NO.-O03.4)
Exclusion Criteria
1. Patients with untreated urogenital infections.
2. Patients suffering from any chronic debilitating disease like diabetes mellitus hypertension,
sexually transmitted disease, hepatitis B.
3. Patients not willing to be included in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expulsion of retained products of conceptionTimepoint: Maximum 8 days of drug intervention <br/ ><br>FOLLOW-UP <br/ ><br>Patient will be monitored daily during basti and will be advised for repeat ultrasonography <br/ ><br>(USG) after treatment.
- Secondary Outcome Measures
Name Time Method 1. Stops P/V Bleeding <br/ ><br>2. Relief in abdominal pain <br/ ><br>Timepoint: Maximum 8 days of drug intervention <br/ ><br>FOLLOW-UP <br/ ><br>Patient will be monitored daily during basti and will be advised for repeat ultrasonography <br/ ><br>(USG) after treatment.